Volvo Cars, the premium car maker, today unveiled two new concept cars that move the Swedish brand in an audacious new direction and mark the official launch of its global small car strategy.
Today’s newly-revealed 40 series concepts demonstrate for the first time how Volvo Cars plans to expand into the large and lucrative global market for premium small cars with a range of vehicles that combine bold exterior and interior design with industry-leading connectivity, electrification and autonomous drive technologies.
The new concept cars will be the first built around Volvo Cars’ new Compact Modular Architecture (CMA), which has been specially created for smaller cars and which has liberated the company’s designers and engineers to explore bold and daring new directions.
“Each member of our product family has its own distinct character, just like the members of a real family. CMA has helped us to capture something special, something youthful in our new concept cars. They have an energy, a disruptive and engaging urban character that makes them stand out amongst the crowd. This is the flavour of small Volvos to come,” said Thomas Ingenlath, Senior Vice President, Design, at Volvo Car Group.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7837051-volvo-new-range-of-smaller-cars/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
BLACK+DECKER™ announces its new line of robotic vacuums, the SMARTECH™ Robotic Vacuums. The new robotic vacuums connect to the BLACK+DECKER Mobile App via Bluetooth® Technology so homeowners can control the vacuum from their smartphone. Within the app, users can select a cleaning mode, program a cleaning schedule, drive the vacuum to a specific location, and customize the color of the robot’s LED top to fit the owner’s style on two of the three models. With a long runtime, a large capacity dustbin, and a wide 9" cleaning path, homeowners can count on the SMARTECH™ Robotic Vacuum to get the job done.
To view the multimedia release go to:
http://www.multivu.com/players/English/8005951-black-decker-smartech-robotic-vacuums/
Ethicon*, a trusted leader in advancing wound closure, announces the launch of STRATAFIX™ Spiral PDS Plus and STRATAFIX™ Spiral Monocryl Plus Knotless Tissue Control Devices. With the addition of these two new suture technologies to the STRATAFIX™ Family of Knotless Tissue Control Devices, Ethicon has established the most comprehensive and unmatched knotless suture offering available to surgeons in the U.S.
STRATAFIX™ Knotless Tissue Control Devices transforms the wound closure experience by providing unique advantages over traditional sutures. STRATAFIX™ sutures provide more strength and security, more consistency and more efficiency than traditional suturing. The portfolio of knotless sutures also enables surgeons to more easily manage tension and control tissue approximation with each pass during closure and eliminates the need to tie knots.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889651-ethicon-new-stratafix-suture/
